Skip to main content
Institutional deep-dive - valuation, health, statements

Financial Analysis

Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data

Fundamentals

AEON Biopharma, Inc. AEON

· Materials · Pharmaceutical Preparations

Fundamentals
SEC EDGAR

Filing evidence summary

Caution evidenceCoverage 2/5 core metrics

Latest reported free cash flow was -$17M.

Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.

Evidence signals

  • Free cash flow was negative

    Latest reported free cash flow was -$17M.

    Why this surfaced

    Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.

  • Shareholders' equity was non-positive

    Debt/equity is shown as not meaningful rather than as a negative leverage ratio.

    Why this surfaced

    Same-period reported shareholders' equity was zero or negative; review the balance sheet and capital structure. Period end 2023-12-31.

  • 2 filing risk checks flagged

    Flagged areas: Solvency & liquidity.

    Why this surfaced

    The full financial analysis shows each value, threshold, and sector limitation.

Core trend metrics

Free cash flow
-$17M
as of 2025-12-31
Debt / equity
N/M
as of 2023-12-31

Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.

Where to look next

Risk checks

2of 5 rule-based checks flagged
  • Solvency & liquidity

Financial movement

  • Cash→ flat
  • Long-term debt→ flat
  • Inventory→ flat
  • Receivables→ flat
  • Current assets→ flat

Source & freshness

Source
SEC EDGAR XBRL
Fetched
2026-09-06
Latest period end
2025-12-31
Filings
EDGAR ↗

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing
Fiscal year ending 2025-12-3110-K filed 2026-03-30prior period 2024-12-31 from the same filingView filing
By business segment
Operating income
  • Single Reportable Segment-$12.8M
    100.0%
    -117.5% yoy

Members sum to the consolidated -$12.8M for this period.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

Peer percentiles

latest fiscal year ending 2025-12-31 · among 4,122 US-listed filers · 797 in Materials
MetricValuevs all filersvs sector
Cash-flow accrual ratio
(net income − operating cash flow) ÷ average total assets · lower is ranked higher
-503.6%
100thof 3,577
top third
100thof 673
top third
Balance-sheet accrual ratio
change in net operating assets ÷ average net operating assets · lower is ranked higher
68.0%
13thof 3,059
bottom third
22ndof 593
bottom third

Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.

Earnings quality

latest fiscal year ending 2025-12-31 · accruals and cash conversion as filed
Cash conversion
-
operating cash flow ÷ net income, latest fiscal year
Cash-flow accrual ratio
-503.7%
(net income − operating cash flow) ÷ average total assets
Balance-sheet accrual ratio
68.0%
change in net operating assets ÷ average net operating assets
Cash-backed years
1 of 2
fiscal years where operating cash flow met or exceeded net income
Mean cash conversion
-0.48×
across the stored fiscal years with positive net income

Per fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.

Point-in-time ledger

first-reported vs latest filing · periods since 2020-01-01 · 26 changed periods
Line itemPeriodFirst reportedLatest filingChangeFilings
Net income
NetIncomeLoss
quarter 2023-03-31-$389K
10-Q 2023-05-17
-$17.6M
10-Q 2024-05-14
-4440.1%first · latest · 3 filings carry it
Operating cash flow
NetCashProvidedByUsedInOperatingActivities
fiscal year 2022-12-31-$981K
10-K 2023-02-22
-$35.6M
10-K/A 2024-05-14
-3525.7%first · latest · 5 filings carry it
Stockholders' equity
StockholdersEquity
balance at 2022-12-31-$9.44M
10-K 2023-02-22
-$288M
10-K/A 2024-05-14
-2946.5%first · latest · 9 filings carry it
Operating income
OperatingIncomeLoss
quarter 2022-09-30-$488K
10-Q 2022-11-14
-$9.91M
10-Q/A 2024-03-29
-1930.9%first · latest · 3 filings carry it
Operating cash flow
NetCashProvidedByUsedInOperatingActivities
quarter 2023-03-31-$624K
10-Q 2023-05-17
-$11.1M
10-Q 2024-05-14
-1672.3%first · latest
Operating income
OperatingIncomeLoss
fiscal year 2022-12-31-$3.33M
10-K 2023-02-22
-$48.4M
10-K/A 2024-05-14
-1356.3%first · latest · 5 filings carry it
Total liabilities
Liabilities
balance at 2022-12-31$10.4M
10-K 2023-02-22
$143M
10-K/A 2024-05-14
+1271.6%first · latest · 9 filings carry it
Net income
NetIncomeLoss
quarter 2022-09-30$1.64M
10-Q 2022-11-14
-$10.4M
10-Q/A 2024-03-29
-735.5%first · latest · 3 filings carry it
Operating income
OperatingIncomeLoss
quarter 2023-03-31-$1.74M
10-Q 2023-05-17
-$13M
10-Q 2024-05-14
-648.3%first · latest
Net income
NetIncomeLoss
fiscal year 2022-12-31$9.98M
10-K 2023-02-22
-$52.6M
10-K/A 2024-05-14
-626.6%first · latest · 5 filings carry it
Stockholders' equity
StockholdersEquity
balance at 2021-06-30$5M
10-Q 2021-08-16
-$22.8M
10-Q 2022-11-14
-556.7%first · latest · 6 filings carry it
Stockholders' equity
StockholdersEquity
balance at 2021-03-31$5M
10-Q 2021-06-15
-$18.8M
10-Q 2022-11-14
-476.9%first · latest · 9 filings carry it
Operating income
OperatingIncomeLoss
quarter 2023-06-30-$3.53M
10-Q 2023-07-21
-$14M
10-Q 2024-08-12
-296.2%first · latest
Net income
NetIncomeLoss
quarter 2023-06-30-$3.94M
10-Q 2023-07-21
-$15.4M
10-Q 2024-08-12
-290.1%first · latest
Operating cash flow
NetCashProvidedByUsedInOperatingActivities
quarter 2021-03-31$555K
10-Q 2021-06-15
-$555K
10-Q 2022-05-12
-200.0%first · latest · 3 filings carry it
Operating income
OperatingIncomeLoss
quarter 2021-03-31$201K
10-Q 2021-06-15
-$201K
10-Q 2022-05-12
-200.0%first · latest · 3 filings carry it
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2024-03-3137,268,074 shares
10-Q 2024-05-14
517,915 shares
10-Q 2025-05-14
-98.6%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2024-06-3038,843,627 shares
10-Q 2024-08-12
539,840 shares
10-Q 2025-08-12
-98.6%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2024-09-3039,515,292 shares
10-Q 2024-11-13
549,175 shares
10-Q 2025-11-14
-98.6%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2024-03-3137,268,074 shares
10-Q 2024-05-14
517,915 shares
10-Q 2025-05-14
-98.6%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2024-06-3038,843,627 shares
10-Q 2024-08-12
539,840 shares
10-Q 2025-08-12
-98.6%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2024-09-3039,515,292 shares
10-Q 2024-11-13
549,175 shares
10-Q 2025-11-14
-98.6%first · latest
Total assets
Assets
balance at 2022-12-31$279M
10-K 2023-02-22
$10.8M
10-K/A 2024-05-14
-96.1%first · latest · 9 filings carry it
Debt issued
ProceedsFromNotesPayable
quarter 2021-03-31$360K
10-Q 2021-06-15
$35.2K
10-Q 2022-05-12
-90.2%first · latest · 3 filings carry it
Stockholders' equity
StockholdersEquity
balance at 2023-09-30-$122M
10-Q 2023-11-13
-$128M
10-Q/A 2024-03-29
-5.5%first · latest
Total liabilities
Liabilities
balance at 2023-09-30$139M
10-Q 2023-11-13
$146M
10-Q/A 2024-03-29
+4.8%first · latest

First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.

Notes by disclosure type

Not available for AEON yet: no footnote text blocks on file for this filer in the ingested DERA files.

Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.

Educational content only. Not financial advice. TrendNalysis provides educational and informational financial analysis built from public SEC filings and economic data (FRED, BLS). It is not financial, investment, tax, or legal advice and is not a recommendation to buy or sell any security. Market pricing is not currently included. Past performance does not guarantee future results. Always do your own research and consult a licensed financial professional before investing.